12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

  • Unicycive Therapeutics UNCY shares increased by 114.3% to $1.05 during Monday's pre-market session. The company's market cap stands at $15.8 million.
  • BridgeBio Pharma BBIO stock moved upwards by 56.39% to $17.0. The market value of their outstanding shares is at $2.5 billion.
  • vTv Therapeutics VTVT stock increased by 48.51% to $1.2. The company's market cap stands at $97.7 million.
  • Kala Pharmaceuticals KALA shares increased by 27.46% to $21.35. The company's market cap stands at $39.9 million. The company's, Q4 earnings came out yesterday.
  • TCR2 Therapeutics TCRR shares rose 25.61% to $1.52. The market value of their outstanding shares is at $58.7 million.
  • Armata Pharmaceuticals ARMP shares increased by 16.66% to $3.22. The market value of their outstanding shares is at $116.3 million.

Losers

  • Aclaris Therapeutics ACRS shares decreased by 36.5% to $8.11 during Monday's pre-market session. The company's market cap stands at $540.8 million.
  • Esperion Therapeutics ESPR stock decreased by 33.76% to $4.2. The market value of their outstanding shares is at $321.6 million.
  • Adaptimmune Therapeutics ADAP stock decreased by 26.14% to $1.3. The company's market cap stands at $212.9 million. The company's, Q4 earnings came out today.
  • Rubius Therapeutics RUBY shares declined by 19.94% to $0.1. The company's market cap stands at $9.0 million.
  • Sesen Bio SESN shares declined by 13.25% to $0.54. The company's market cap stands at $108.4 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Etao International Co ETAO stock fell 12.84% to $1.97. The company's market cap stands at $208.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!